Literature DB >> 11991179

Production of core and virus-like particles with baculovirus infected insect cells.

Luis Maranga1, Pedro E Cruz, John G Aunins, Manuel J T Carrondo.   

Abstract

In this paper the fundamental aspects of process development for the production of core and virus-like particles with baculovirus infected insect cells are reviewed. The issues addressed include: particle formation and monomer composition, chemical and physical conditions for optimal cell growth, baculovirus replication and product expression, multiplicity of infection strategy, and scale-up of the process. Study of the differences in the metabolic requirements of infected and non-infected cells is necessary for high cell density processes. In the bioreactor, the specific oxygen uptake rate (OURsp) plays a central role in process scale-up, leading to the specification of the bioreactor operational parameters. Shear stress can also be an important variable for bioreactor operation due to its influence on cell growth and product expression. The determination of the critical variables in process development is discussed, showing the relevance of the mathematical models that have been developed for the insect cells/baculovirus system in process implementation and control.

Entities:  

Mesh:

Year:  2002        PMID: 11991179     DOI: 10.1007/3-540-45736-4_9

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  9 in total

1.  Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay.

Authors:  Young-Joon Ko; Kang-Seuk Choi; Jin-Ju Nah; David J Paton; Jae-Ku Oem; Ginette Wilsden; Shien-Young Kang; Nam-In Jo; Joo-Ho Lee; Jae-Hong Kim; Hee-Woo Lee; Jong-Myeong Park
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

2.  Nutritional demands and metabolic characteristics of the DSIR-HA-1179 insect cell line during growth and infection with the Oryctes nudivirus.

Authors:  Charlotte Pushparajan; Juan Daniel Claus; Sean D G Marshall; Gabriel Visnovsky
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-12-01       Impact factor: 2.416

Review 3.  Baculovirus as versatile vectors for protein expression in insect and mammalian cells.

Authors:  Thomas A Kost; J Patrick Condreay; Donald L Jarvis
Journal:  Nat Biotechnol       Date:  2005-05       Impact factor: 54.908

Review 4.  SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies.

Authors:  Lanxiang Huang; Yuan Rong; Qin Pan; Kezhen Yi; Xuan Tang; Qian Zhang; Wei Wang; Jianyuan Wu; Fubing Wang
Journal:  Asian J Pharm Sci       Date:  2020-09-01       Impact factor: 6.598

Review 5.  Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks.

Authors:  Stanislav Sokolenko; Steve George; Andreas Wagner; Anup Tuladhar; Jonas M S Andrich; Marc G Aucoin
Journal:  Biotechnol Adv       Date:  2012-01-28       Impact factor: 14.227

Review 6.  Engineered biological entities for drug delivery and gene therapy protein nanoparticles.

Authors:  Joan Domingo-Espín; Ugutz Unzueta; Paolo Saccardo; Escarlata Rodríguez-Carmona; José Luís Corchero; Esther Vázquez; Neus Ferrer-Miralles
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 7.  Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform.

Authors:  Nawamin Sa-Nguanmoo; Katawut Namdee; Mattaka Khongkow; Uracha Ruktanonchai; YongXiang Zhao; Xing-Jie Liang
Journal:  Nano Res       Date:  2021-10-09       Impact factor: 10.269

8.  Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine.

Authors:  Zhiyong Li; Yongzhu Yi; Xiangping Yin; Zhifang Zhang; Jixing Liu
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

9.  Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity.

Authors:  Hao Feng; Gui-qiu Hu; Hua-lei Wang; Meng Liang; Hongru Liang; He Guo; Pingsen Zhao; Yu-jiao Yang; Xue-xing Zheng; Zhi-fang Zhang; Yong-kun Zhao; Yu-wei Gao; Song-tao Yang; Xian-zhu Xia
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.